Form D · Biotechnology
Advanced Tear Diagnostics, LLC
Birmingham, AL · CIK 0001682928
Offering snapshot reported Oct 17, 2016 · SEC filing
- Reported sold
- $385K Offering amount: $385K
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $15K Reported outside-investor minimum
- First sale
- Mar 22, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 17, 2016 | Initial | $385,000 | No comparison | 10 | SEC filing |
| Sep 15, 2016 | Initial | $1,416,574 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-272687
Source: Form D, filed Oct 17, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeffrey Busby | Executive |
| Andrew Penman | Executive |
| Marcus Smith | Director, Executive |
| Catalina Valencia | Executive |
| Gene Wahnefried | Executive |
| Pierce Youngbar | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3303 Culloden Way
Birmingham, AL, 35242
Birmingham, AL, 35242